Other Clinical Trial - Extracorporeal Membrane Oxygenation (ECMO)

Status Completed

Clinical Trial Summary

Since the 1970s, extracorporeal membrane oxygenation (ECMO) support has been used to support gas exchange for children with severe acute respiratory failure who fail mechanical ventilation. ECMO is more expensive than each of these other procedures.But its action is unclear

Clinical Trial Description

Since 1974, eight randomized controlled trials have been reported in ECMO for respiratory failure, and none have included non-neonatal pediatric patients. Cochrane systematic reviews of this evidence concluded that ECMO for neonatal respiratory failure had a survival advantage, but there was insufficient evidence to demonstrate a survival advantage for ECMO used to support respiratory failure in adults. Moreover, these trials were performed prior to 2009, and since then advances in ECMO technology have enhanced the delivery of ECMO support, and new research has changed conventional management of severe acute respiratory distress syndrome (ARDS) ;

Study Design

Related Conditions & MeSH terms

Extracorporeal Membrane Oxygenation

Clinical Trial Details

NCT number	NCT03607760
Study type	Observational
Source	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Contact
Status	Completed
Phase
Start date	November 11, 2018
Completion date	April 4, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03685383` - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation	N/A
Not yet recruiting	`NCT05106491` - Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients	N/A
Recruiting	`NCT05699005` - Individualized or Conventional Transfusion Strategies During Peripheral VA-ECMO	Phase 1
Recruiting	`NCT05444764` - PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
Completed	`NCT05038943` - Evaluation of Safety and Effectiveness of The SherpaPak in Donation After Circulatory Death Heart Transplantation	N/A
Not yet recruiting	`NCT05341687` - Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.
Suspended	`NCT04385771` - Cytokine Adsorption in Patients With Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation	N/A
Recruiting	`NCT03766282` - Pharmacokinetics in Extracorporeal Membrane Oxygenation
Completed	`NCT03355625` - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed	`NCT01521195` - Oxygen Consumption In Critically Ill Children	N/A
Recruiting	`NCT04620070` - ON-SCENE Initiation of Extracorporeal CardioPulmonary Resuscitation During Refractory Out-of-Hospital Cardiac Arrest	N/A
Recruiting	`NCT06062212` - Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
Recruiting	`NCT05730114` - Monitoring Antiplatelet Drugs in Cardiac Arrest Patients
Completed	`NCT05154071` - Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality
Recruiting	`NCT04536272` - Reduced Anticoagulation Targets in ECLS (RATE)	Phase 3
Completed	`NCT05693051` - Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
Completed	`NCT03764319` - Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO	N/A
Recruiting	`NCT05762029` - Treatment of Extracorporeal Membrane Oxygenation in Severe Poisoning
Completed	`NCT02995811` - Characterising Changes in Muscle Quantity and Quality in Patients Requiring ECMO Oxygen During Critical Illness
Recruiting	`NCT04754854` - Reduction of Blood Recirculation in Veno-Venous ECMO